6-K ·Filed Jul 6, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor upcoming clinical catalysts for muzastotug (Phase 2 data) which remain the primary stock price driver. Cash position supports operations into early 2028 per prior guidance.
Final — all horizons settled through T+60d
ADAG ▼ -18.32% at T+60d
NEUTRAL call -18.32% · α vs SPY -20.04% · entry $3.93 → $3.21
T+1d
0.00%
call 0.00% · α +0.48%
$3.93
settled 4mo ago
T+5d
+0.25%
call +0.25% · α -0.23%
$3.94
settled 4mo ago
T+20d
-4.58%
call -4.58% · α -4.01%
$3.75
settled 3mo ago
T+60d
-18.32%
call -18.32% · α -20.04%
$3.21
settled 28d ago
Price Chart
Loading chart...
Executive Summary
Adagene disclosed preliminary unaudited cash and cash equivalents of $127.9 million as of June 30, 2026 in a routine 6-K filing. The amount is consistent with prior guidance on cash runway into early 2028. No other financial or operational updates were provided.
Key Facts
- Cash and cash equivalents of $127.9M as of June 30, 2026, preliminary and unaudited
- Filed as Form 6-K on July 6, 2026 for month of July 2026
- No other financial or operational disclosures in this filing
Financial Impact
Cash position of $127.9M disclosed; no impact on revenue or earnings
cash
Risk Factors
- Preliminary cash figure subject to finalization in audited financials
- No updates on pipeline progress or regulatory developments
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (12 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-080580 |
| Document: 0001104659-26-080580-index-headers.html | 0001104659-26-080580 |
| Document: 0001104659-26-080580-index.html | 0001104659-26-080580 |
| Document: 0001104659-26-080580.txt | 0001104659-26-080580 |
16 reports for ADAG
60% Hit rate @ T+60 Went positive at some point 5 of 7 best @ T+1▲ +8.27%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | 6-K | $3.20 | awaiting T+60 | — | $2.49 (−22.19%) |
Sep 22, 2026 4w ago | 6-K | $3.23 | awaiting T+60 | — | $2.49 (−22.91%) |
Sep 10, 2026 6w ago | 6-K | $3.31 | awaiting T+60 | — | $2.49 (−24.77%) |
Sep 9, 2026 6w ago | 6-K | $3.27 | awaiting T+60 | — | $2.49 (−23.85%) |
Aug 16, 2026 10w ago | Institutional Cluster | $3.83 | awaiting T+60 | — | $2.49 (−34.99%) |
Aug 12, 2026 10w ago | 6-K | $3.75 | awaiting T+60 | — | $2.49 (−33.60%) |
Aug 12, 2026 10w ago | Press Release | $3.75 | awaiting T+60 | — | $2.49 (−33.60%) |
Jul 6, 2026 16w ago | 6-K | $3.93 $3.21 | ▼ −18.32% | ▼ −20.04% | $2.49 (−36.64%) |
Apr 17, 2026 27w ago | 6-K | $3.89 $3.67 | ▼ −5.66% | ▼ −12.43% | $2.49 (−35.99%) |
Apr 2, 2026 29w ago | 6-K | $3.99 $4.20 | ▼ −5.26% | ▲ +8.90% | $2.49 (+37.59%) |
Showing 10 of 16
US Market Status
Market Closed — Opens in 1h 53m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers